1
Clinical Trials associated with Human normal immunoglobulin(Guangdong Shuanglin Biological Pharmaceutical )评价静注人免疫球蛋白(10%)在成人及青少年中治疗原发免疫性血小板减少症(ITP)有效性和安全性的单臂、开放、多中心临床研究
[Translation] A single-arm, open-label, multicenter clinical study to evaluate the efficacy and safety of intravenous human immunoglobulin (10%) in the treatment of primary immune thrombocytopenia (ITP) in adults and adolescents
评价广东双林生物制药有限公司生产的静注人免疫球蛋白(10%)在成人及青少年中治疗持续性和慢性原发免疫性血小板减少症(ITP)的有效性和安全性。
[Translation] To evaluate the efficacy and safety of intravenous human immunoglobulin (10%) produced by Guangdong Shuanglin Biopharmaceutical Co., Ltd. in the treatment of persistent and chronic primary immune thrombocytopenia (ITP) in adults and adolescents.
100 Clinical Results associated with Human normal immunoglobulin(Guangdong Shuanglin Biological Pharmaceutical )
100 Translational Medicine associated with Human normal immunoglobulin(Guangdong Shuanglin Biological Pharmaceutical )
100 Patents (Medical) associated with Human normal immunoglobulin(Guangdong Shuanglin Biological Pharmaceutical )
100 Deals associated with Human normal immunoglobulin(Guangdong Shuanglin Biological Pharmaceutical )